Intralesional Pentoxifylline Injection Versus Triamcinolone Acetonide in Treating Localized Alopecia Areata: A Comparative Study

November 2023 in “ PubMed ”

Hamed Mohamed Abdo, Emad Mahmoud El-Rewiny, Ahmed Shawky, Amr Mohammad Ammar, Atef Ahmed, Mahmoud A. Rageh

pentoxifylline triamcinolone acetonide alopecia areata intralesional injection terminal hair regrowth PTX TRA localized AA

From the encyclopedia

Triamcinolone Acetonide →

Alopecia Areata →

autoimmune disorder causing patchy hair loss

Studysummary This study showed that intralesional injections of pentoxifylline may be an effective and safe alternative to triamcinolone acetonide for treating localized alopecia areata. Our plain-language summary of this paper — not a Tressless recommendation.

This study compared the efficacy of intralesional pentoxifylline (PTX) and triamcinolone acetonide (TRA) injections in treating localized alopecia areata (AA) in 60 patients. Both treatments were found to be effective, with PTX showing a high response (66-100% terminal hair regrowth) in 50% of patients and TRA in 46.6% of patients. Despite the small sample size and short follow-up period, the study concluded that PTX is a safe and effective alternative to TRA for localized AA.

View this study on pmc.ncbi.nlm.nih.gov →

Discuss this study in the Community →

Research cited in this study

10 / 10 results

research Intralesional Pentoxifylline Injection in Localized Alopecia Areata

3 citations , October 2018 in “Journal of cosmetic dermatology”

This study found that intralesional pentoxifylline injections were effective for localized alopecia areata, with the best results observed when combined with triamcinolone acetonide.

research Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata

11 citations , April 2015 in “EBioMedicine”

This research highlights that JAK inhibitors, such as baricitinib, may effectively reverse symptoms of alopecia areata by targeting specific immune pathways, though safety and efficacy require further investigation.

research Role of Platelet-Rich Plasma in Chronic Alopecia Areata: Our Centre Experience

61 citations , January 2015 in “Indian Journal of Plastic Surgery”

This study found that platelet-rich plasma may have a role in treating chronic alopecia areata, but more long-term follow-up studies are needed to confirm its effectiveness and success rate.

research Evaluation and Diagnosis of the Hair Loss Patient

69 citations , August 2014 in “Journal of The American Academy of Dermatology”

This review discusses recent advances in trichoscopy for differentiating types of alopecia and presents a systematic approach for using its diagnostic findings, but reports no new clinical results.

research Serum Granulysin as a Possible Key Marker of the Activity of Alopecia Areata

26 citations , September 2013 in “Journal of Dermatological Science”

In this study, researchers found that serum granulysin levels might serve as a novel marker for disease activity in acute alopecia areata, being significantly associated with broader bald skin areas, poorer prognosis, and co-existing allergic disorders.

research Topical and Intralesional Therapies for Alopecia Areata

36 citations , May 2011 in “Dermatologic therapy”

This review discusses topical and intralesional treatments for alopecia areata, providing a management strategy based on patient age and disease severity, but reports no new clinical results.

research Alopecia Areata Update

391 citations , January 2010 in “Journal of The American Academy of Dermatology”

This article reviews the clinical presentation and histopathologic features of alopecia areata and proposes a hypothesis for its development, but it reports no new clinical results.

research Alopecia Areata: Evidence-Based Treatments

71 citations , March 2009 in “Seminars in cutaneous medicine and surgery”

This review discusses evidence for alopecia areata treatments, highlighting their ability to stimulate hair growth but noting limited data on long-term efficacy and impact on quality of life.

research Treatment of Persistent Alopecia Areata with Sulfasalazine

45 citations , July 2008 in “International Journal of Dermatology”

This study found that oral sulfasalazine led to varying hair regrowth outcomes in patients with persistent alopecia areata, with 56.3% showing moderate to good responses.

research Hair Regrowth

118 citations , April 1998 in “Dermatologic Clinics”

This review discusses the advancements in understanding and treating androgenetic alopecia and alopecia areata but reports no clinical findings; the authors emphasize the need for further research on molecular control mechanisms.